MAM

MPM Asset Management Portfolio holdings

AUM $43.3M
This Quarter Return
+53.88%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$450M
AUM Growth
+$450M
Cap. Flow
+$31.6M
Cap. Flow %
7.01%
Top 10 Hldgs %
97.57%
Holding
15
New
2
Increased
Reduced
1
Closed

Sector Composition

1 Healthcare 28.59%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RDUS
1
DELISTED
Radius Health, Inc.
RDUS
$227M 50.39% 5,831,253
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$45.5M 10.12% 2,413,819
PETX
3
DELISTED
Aratana Therapeutics, Inc.
PETX
$37.8M 8.39% 2,118,845
PTLA
4
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$34.6M 7.68% 1,220,672
NVRO
5
DELISTED
NEVRO CORP.
NVRO
$26.6M 5.9% +686,704 New +$26.6M
TRIV
6
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$22.3M 4.96% 1,776,692
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$15.6M 3.47% 800,542 -266,694 -25% -$5.21M
ALT icon
8
Altimmune
ALT
$338M
$11.5M 2.55% 6,347,614
TARA icon
9
Protara Therapeutics
TARA
$120M
$10.2M 2.27% +983,381 New +$10.2M
HSTO
10
DELISTED
Histogen Inc. Common Stock
HSTO
$8.35M 1.85% 1,192,080
VSTM icon
11
Verastem
VSTM
$569M
$7.46M 1.66% 816,683
ETRM
12
DELISTED
EnteroMedics Inc.
ETRM
$1.58M 0.35% 1,113,168
SVRA icon
13
Savara
SVRA
$567M
$1.43M 0.32% 2,551,851
SGMO icon
14
Sangamo Therapeutics
SGMO
$157M
$342K 0.08% 22,487
MGNX icon
15
MacroGenics
MGNX
$112M
$111K 0.02% 3,168